Krajina: Austrália
Jazyk: angličtina
Zdroj: APVMA (Australian Pesticides and Veterinary Medicines Authority)
DEXAMETHASONE AS THE SODIUM PHOSPHATE
INTERVET AUSTRALIA PTY LIMITED
dexamethasone as sod.phosphate(2mg/mL)
PARENTERAL LIQUID/SOLUTION/SUSPENSION
DEXAMETHASONE AS THE SODIUM PHOSPHATE STEROID-GLUCOCORTICOID Active 2.0 mg/ml
50mL
VM - Veterinary Medicine
INTERVET AUSTRALIA
CAT | CATTLE | DOG | GOAT | HORSE | PIGS | SHEEP | BEEF | BILLY | BITCH | BOAR | BOS INDICUS | BOS TAURUS | BOVINE | BUCK | BUFF
ENDOCRINE SYSTEM
CORTICOSTEROID | ADVANCING PARTURITION | ALLERGIC REACTIONS | ANTIADRENAL SUPPRESSION | ANTI-INFLAMMATORY | ANTISHOCK | ARTHRITIS | BRONCHITIS | CATABOLIC COMPLICATIONS | CHRONIC BRONCHITIS | CORTICOSTEROIDS | CORTICOSTEROIDS AND RELATE | COUGHS | DERMATITIS | DERMATOLOGICAL DISORDERS | DERMATOSES | ECZEMA | GLUCOGENIC STEROID | JOINT DISEASE | KETOSIS | LOCOMOTIVE DISEASES | MUSCULO SKELETAL INFLAMMAT | ORTHOPAEDIC | PARTURIENT UDDER OEDEMA | PARTURITION | PRURITIS | RESPIRATORY TRACT DISEASES | RHEUMATIC DISEASES | STRESS | TOXAEMIA | WATER RETENTION
Poison schedule: 4; Withholding period: WHP: MEAT: DO NOT USE less than 14 days Cattle & Pigs and 28 days Horses Sheep & Goats before slaughter for human consumption. MILK: Milk collecte d from Cattle within 3 days and Sheep & amp; Goats within 7 days following trea tment MUST NOT BE USED for human consum ption or processing. This milk should n ot be fed to bobby calves. EXPORT SLAU GHTER INTERVAL (ESI): This product does not have an ESI established; Host/pest details: CAT: [CORTICOSTEROID]; CATTLE: [CORTICOSTEROID]; DOG: [CORTICOSTEROID]; GOAT: [CORTICOSTEROID]; HORSE: [CORTICOSTEROID]; PIGS: [CORTICOSTEROID]; SHEEP: [CORTICOSTEROID]; Poison schedule: 4; Withholding period: ; Host/pest details: CAT: [CORTICOSTEROID]; CATTLE: [CORTICOSTEROID]; DOG: [CORTICOSTEROID]; GOAT: [CORTICOSTEROID]; HORSE: [CORTICOSTEROID]; PIGS: [CORTICOSTEROID]; SHEEP: [CORTICOSTEROID]; Aqueous solution of dexamethasone for intravenous, intramuscular or intra- articular injection for use in horses, cattle, sheep, goats, pigs, dogs and cats.Contraindications: Diabetes mellitus, osteoporosis, cardiac and renal diseases
Registered
2023-07-01
DEXADRESON ® INJECTION DEXADRESON ® DEXADRESON ® 045765 CBU880 03 45x45x90 185C, black 189 Batch No.: / Expiry: DISPOSAL: Dispose of empty containers by wrapping with paper and putting in garbage. STORAGE: Store below 25°C (Air conditioning). Protect from light. APVMA Approval No.: 52298/50M/0410 INTERVET AUSTRALIA PTY LIMITED 91-105 Harpin Street, BENDIGO EAST VIC 3550 Phone: (03) 5440 9888 WARRANTY Intervet Australia Pty Ltd (IAPL) warrants that this product is of merchantable quality and fit for its intended purpose. IAPL's liability for any loss, including consequential losses or injury caused by act or omission, including negligent acts or omissions, by IAPL or its agent, is limited to replacing or repairing the product at the option of IAPL. If possible, a sample of any product causing concern should be retained or delivered to IAPL within 30 days for a scientific examination. READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT. DIRECTIONS FOR USE: STORE UPRIGHT. USE ALL CONTENTS WITHIN 4 WEEKS OF OPENING All parenteral routes may be used in all species at a rate of 3 mL/100 kg. Normal aseptic technique should be observed. WITHHOLDING PERIODS: MEAT: DO NOT USE LESS THAN 14 DAYS CATTLE & PIGS AND 28 DAYS HORSES, SHEEP & GOATS BEFORE SLAUGHTER FOR HUMAN CONSUMPTION. MILK: MILK COLLECTED FROM CATTLE WITHIN 3 DAYS AND SHEEP & GOATS WITHIN 7 DAYS FOLLOWING TREATMENT MUST NOT BE USED FOR HUMAN CONSUMPTION OR PROCESSING. THIS MILK SHOULD NOT BE FED TO BOBBY CALVES. TRADE ADVICE: EXPORT SLAUGHTER INTERVAL (ESI): This product does not have an ESI established.For advice on the ESI, contact the manufacturer on 1800 033461 before using this product. FIRST AID: If poisoning occurs, contact a doctor or Poisons Information Centre. Phone Australia 13 11 26 PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY DEXADRESON ® INJECTION DEXAMETHASONE 2 MG/ML (AS SODIUM PHOSPHATE) Aqueous solution of dexamethasone for intravenous, intramuscular or intra-articular injection for use in Horses, Cat Prečítajte si celý dokument
PRODUCT NAME: DEXADRESON® INJECTION MATERIAL SAFETY DATA SHEET THIS REVISION ISSUED: JULY, 2009 PAGE: 1 OF 6 MATERIAL SAFETY DATA SHEET Issued by: Intervet Australia Pty Limited Phone: 1 800 033 461 (Business Hours) Poisons Information Centre: 13 11 26 from anywhere in Australia, (0800 764 766 in New Zealand) SUBSTANCE: Water solution of ingredients. Dexadreson sodium phosphate sterile injection. TRADE NAME: DEXADRESON ® INJECTION PRODUCT CODE: 21125 RECOMMENDED USE: Anti- inflammatory injection for use in horses, cattle, sheep, pigs, dogs and cats as indicated on the product label.. APVMA NO: 52298 CREATION DATE: November, 2006 THIS VERSION ISSUED: July, 2009 and is valid for 5 years from this date. STATEMENT OF HAZARDOUS NATURE: THIS PRODUCT IS CLASSIFIED AS: Not classified as hazardous according to the criteria of SWA. Not a Dangerous Good according to the Australian Dangerous Goods (ADG) Code. RISK PHRASES: Not Hazardous - No criteria found. SAFETY PHRASES: S25, S45. Avoid contact with eyes. In case of accident or if you feel unwell, contact a doctor or Poisons Information Centre immediately (show the label where possible). SUSDP CLASSIFICATION: S4 ADG CLASSIFICATION: None allocated. Not a Dangerous Good under the ADG Code. UN NUMBER: None allocated PHYSICAL DESCRIPTION & COLOUR: Clear, colourless liquid. ODOUR: Slight alcohol odour. MAJOR HEALTH HAZARDS: no significant risk factors have been found for this product. THIS IS A PHARMACOLOGICALLY ACTIVE MATERIAL USED IN SOME PAIN RELIEVING PREPARATIONS. DESPITE IT BEING RELATIVELY NON-HAZARDOUS, YOU ARE ADVISED TO AVOID CONTACT WITH THIS MATERIAL AS MUCH AS IS PRACTICAL. If injected in large quantities, effects such as Cushing’s syndrome (fat redistribution, bruising, acne and hirsuitism), water retention, electrolyte imbalance (e.g., oedema, low potassium), high blood pressure, hyperglycaemia (high blood glucose) and suppression of adrenal gland secretions may occur. INHALATION: SHORT TERM EXPOSURE: Available data indicates that this product is not harmful. Prečítajte si celý dokument